Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial.
BMJ Open
; 14(6): e077903, 2024 Jun 10.
Article
en En
| MEDLINE
| ID: mdl-38858156
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Radiocirugia
/
Carcinoma Hepatocelular
/
Anticuerpos Monoclonales Humanizados
/
Neoplasias Hepáticas
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
BMJ Open
Año:
2024
Tipo del documento:
Article
País de afiliación:
China